Join Now

Yearly Archives: 2022

Recursion CEO, Chris Gibson, Awarded Governor’s Medal for Science and Technology

Recursion CEO, Chris Gibson, Ph.D., was honored at the One Utah Summit on May 10, receiving the Governor’s Medal for Science and Technology. Gov. Spencer Cox presented the award which recognizes the distinguished service, significant achievement, and positive economic impact of individuals to the state of Utah and beyond in the fields of science and […]

Posted in BioUtah News | Leave a comment

IONIQ Receives Three Awards including ‘Best Medical Technology Company 2022’

IONIQ Receives Three Awards including ‘Best Medical Technology Company 2022’

Posted in BioUtah News | Tagged | Leave a comment

BlueWind Medical Raises $64 Million to Fund Innovative Technology for Overactive Bladder (OAB) Treatment

RENOVA iStim™ implantable tibial neuromodulation device is being studied as a minimally invasive, patient-centric solution for the treatment of OAB.

Posted in BioUtah News | Tagged | Leave a comment

New Executive Appointments Position ARUP Laboratories for Future Growth

New Executive Appointments Position ARUP Laboratories for Future Growth

Posted in BioUtah News | Tagged | Leave a comment

First Patients Outside of U.S. Treated with TRIA Biopolymer Surgical Aortic Heart Valve in India Clinical Trial

Foldax announced that the first patients have been enrolled in the Drugs Controller General of India (DCGI)-approved clinical trial of the TRIATM biopolymer surgical aortic heart valve.

Posted in BioUtah News | Tagged | Leave a comment

E&C Leaders Unveil FDA User Fees Legislative Package

Bipartisan Agreement Will Support Innovation, Lower Costs, and Improve People’s Lives Washington, D.C. – Energy and Commerce Committee Chairman Frank Pallone, Jr. (D-NJ), Ranking Member Cathy McMorris Rodgers (R-WA), Health Subcommittee Chairwoman Anna G. Eshoo (D-CA), and Health Subcommittee Ranking Member Brett Guthrie (R-KY) today unveiled a comprehensive legislative package to reauthorize the Food and Drug […]

Posted in Policy News | Leave a comment

Biomerics Announces Image Guided Intervention (IGI) Division

SALT LAKE CITY, UTAH (Monday, May 2, 2022) – Biomerics, a leading vertically integrated contract manufacturer for the attractive interventional device market, announced the creation of a new division, Biomerics Image Guided Intervention (IGI). Biomerics’ IGI Division, headquartered in Salt Lake City, provides advanced image generation and processing technologies to enable real-time minimally invasive advanced […]

Posted in BioUtah News | Leave a comment

Genovac Acquires Platform for Antibody Screening and Characterization Services

Genovac announces that the company has acquired Carterra’s LSA platform for use in its discovery services. Genovac, previously a part of Aldevron before a management buyout in 2020, has been providing discovery services to life science researchers since 1999 from its site in Freiburg, Germany. More recently, Genovac added production, characterization, and cell line development […]

Posted in BioUtah News | Leave a comment

CoNextions TR Tendon Repair System receives FDA clearance

Expected to launch in May 2022, the novel system addresses traumatic tendon lacerations in the hand, wrist, and forearm CoNextions Inc., an innovator in tendon repair, is pleased to announce that CoNextions TR Tendon Repair System has received FDA 510(k) Clearance. Expected to launch in May 2022, the novel system addresses traumatic tendon lacerations in […]

Posted in BioUtah News | Leave a comment

Blackrock Neurotech and Phantom Neuro Partner to Enable Prosthetics and Exoskeletons that Mimic Human Movement in Real-Time

The Phantom X system uses muscle-sensing implant technology to enable greater mobility in people with orthopedic injuries. SALT LAKE CITY and AUSTIN, Texas, April 26, 2022 /PRNewswire/ — Blackrock Neurotech, an  industry leader in brain-computer interface (BCI) technology, and Phantom Neuro, a recently launched neurotech startup that delivers a high accuracy system for lifelike control of robotic […]

Posted in BioUtah News | Leave a comment

Myriad Genetics Reports First Quarter Revenue and Reiterates Guidance for 2022

Highlights: Revenue of $164.9 million for the quarter ended March 31, 2022 Excluding revenue from divested businesses, revenue increased 11% year-over-year Diluted GAAP earnings per share (EPS) of $(0.26) and adjusted EPS of $(0.03) in the first quarter of 2022 improved by $0.26 and $0.03 year-over-year, respectively Ended the quarter with $339.2 million in cash, […]

Posted in BioUtah News | Leave a comment

BD REPORTS SECOND QUARTER FISCAL 2022 FINANCIAL RESULT

FRANKLIN LAKES, N.J., May 5, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its second quarter of fiscal year 2022, which ended March 31, 2022. Revenue of $5.0 billion increased 2.1% as reported and 3.9% on currency-neutral basis Revenue driven by base revenue growth of […]

Posted in BioUtah News | Leave a comment